Journal Name: Eye and Glaucoma Research
ISSN: 2732-4818
DOI: 10.31021
Indexing: Click Here
Journal Type: Open Access
Contact Us: Click Here
Eye and Glaucoma Research (EGR) is an international, peer-reviewed, open access journal published by Boffin Access Limited, dedicated to advancing knowledge in ophthalmology, vision science, and glaucoma research. The journal serves as a trusted platform for clinicians, researchers, and healthcare professionals to publish innovative findings that enhance the diagnosis, treatment, and prevention of eye diseases, with a special focus on glaucoma—the leading cause of irreversible blindness worldwide.
By promoting high-quality research and fostering global collaboration, EGR contributes to improving vision health, advancing surgical and pharmacological therapies, and reducing the burden of glaucoma and other ocular disorders.
Eye and Glaucoma Research welcomes a wide range of submissions, including original research articles, clinical case studies, reviews, perspectives, and short communications, in areas such as:
Glaucoma: epidemiology, risk factors, and pathophysiology
Advances in glaucoma diagnosis: imaging, biomarkers, and functional testing
Novel medical and surgical therapies for glaucoma
Genetics and molecular biology of ocular diseases
Corneal and retinal disorders: diagnosis and management
Neuro-ophthalmology and optic nerve research
Pediatric and congenital glaucoma
Innovations in ocular pharmacology and drug delivery systems
Artificial intelligence and technology in ophthalmology
Public health and preventive strategies for vision preservation
Specialized Focus – Dedicated to eye health and glaucoma, addressing both clinical and research perspectives.
Rigorous Peer Review – Ensures scientific accuracy, ethical compliance, and originality.
Global Visibility – Open access publishing guarantees unrestricted access to ophthalmologists, researchers, and healthcare professionals worldwide.
Rapid Dissemination – Accepted articles are published online within weeks of acceptance.
Interdisciplinary Platform – Encourages collaboration across ophthalmology, neuroscience, genetics, and public health.
Author Benefits – Authors retain copyright under Creative Commons licensing, ensuring long-term visibility and citation.
Innovative Content Formats – Research can be published in PDF, HTML, and supplementary formats including high-resolution images and surgical videos.
The journal adheres to COPE and ICMJE guidelines, ensuring the highest standards of integrity and professionalism in publishing. Ethical approval is required for clinical and experimental studies, and informed consent is mandatory for case reports.
SCINEXI is committed to upholding the integrity and credibility of the scholarly record. In accordance with international publishing ethics, articles may be retracted when found to contain serious errors, evidence of research misconduct, copyright infringement, or plagiarism. Retraction is a necessary step to safeguard academic reliability and to ensure that the literature remains a trustworthy resource for the global research community.
If you wish to report a concern regarding any published article, please share the details with us by clicking below:
Send Information
Stay connected with SCINEXI. Enter your e-mail address to receive alerts on newly published articles, special issue announcements, and the latest updates from our journals.
At SCINEXI, we actively welcome feedback and constructive criticism. Your compliments, concerns, and suggestions help us refine our services and elevate the author and reader experience.
Have an idea that could advance the Open Access community? We’d love to hear it. Please write to: support@scinexi.com
Copyright © 2025 BOFFIN ACCESS.